ArticleJournal of virology2025
Phospho-activated non-muscle myosin IIA heavy chain supports different mechanisms of virus uptake.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Src-dependent tyrosine-phosphorylation of NM2A has a protective role against bacterial pore-forming toxins.PLoS pathogens · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Limiting virus entry is crucial to prevent infection, since this step of the virus life cycle is a major determinant of cellular tropism, host range, and pathogenesis. We recently showed that the transmembrane protein signal regulatory protein alpha (SIRPA), a negative regulator of F-actin-dependent phagocytosis, limits endocytosis of enveloped RNA viruses from unrelated families. Mechanistically, surface engagement of SIRPA recruits the SH2 domain-containing protein tyrosine phosphatases (SHP)-1 and -2, initiating a signaling cascade that dephosphorylates different pro-phagocytic proteins, including the heavy chain (MYH9) of the molecular motor non-muscle myosin IIA (NM-IIA), to ultimately suppress phagocytosis. Here, we analyzed whether MYH9 would enhance viral infection, as it does phagocytic engulfment, and how its activity in infection is regulated. We found that MYH9 expression increases the infection of viruses exploiting different endocytic pathways/mechanisms to enter cells, including flavivirus, arenavirus, rhabdovirus, and togavirus, in human and mouse cells. Furthermore, we demonstrated that MYH9 is actively translocated to the plasma membrane upon viral infection to support post-binding steps of entry, and that phosphorylation of two key tyrosine residues in its head and tail domains is essential for its function in viral infection. By using small molecule inhibitors and
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.